WE ARE PIONEER IN CHEMOTHERAPY DRUG MANUFACTURING.
We aim to “Transform Lives of patients fighting and living with cancer”. Our company strives to deliver life changing treatment for people and we also reduce the cost of treatment with good quality products. Our Ultimate vision is to provide cure for cancer in all of its form by understanding the disease, its complexities and its impact on patients to provide quality treatment at an affordable price.
We wish to do every possible research and deepen our understanding of the biology and immunology of cancer to make this vision a reality soon.
Kremedine health has invested in ample new and advanced technologies to push the boundaries of cancer research. We have also entered in partnerships regarding the same
Our team of researchers and experts is studying and analysing the cell therapy to engineer T-cell (a type of lymphocyte) so as to target the disease in the best manner possible.
Tumour cell targeting to identify cancer cell-specific traits.
We aim to positively impact the health of people fighting cancer all over the nation and very soon we will also be emerging all over the globe.
Kremedine was established on 17 November 2015. The age of the company is 6 years, 9 months.
A team of well qualified 50 people is associated with Kremedine Health.
The company holds capacity of producing 1,90,00,000 vial of injections annually.
We have major products of our company like - Cisplatin Inj., Vincristine Inj.,Docetaxel Inj., Irinotecan inj., Gemcitabine Inj., Etoposide Inj. Carbaplatin Inj., Cabazitaxel inj., Paclitaxel Inj.
Kremedine health’s main market is in India and Nepal.